isomethyleugenol has been researched along with Hematologic Malignancies in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 6 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhrlage, SJ; Doherty, L; Griffin, JD; Hou, M; Huang, T; Jiang, Y; Jiang, Z; Liu, J; Liu, Q; Magin, RS; Mei, H; Meng, C; Ni, W; Qi, S; Qi, Z; Wang, A; Wang, W; Wang, Z; Weisberg, EL; Yang, J; Zhang, S | 1 |
| Li, F; Xu, YL; Yang, FF | 1 |
| Bomben, R; Cutrona, G; Fais, F; Ferrarini, M; Fronza, G; Gattei, V; Gentile, M; Matis, S; Menichini, P; Monti, P; Morabito, F; Neri, A; Speciale, A; Taiana, E | 1 |
| Hong, M; Li, T; Teng, Y; Wang, Y; Wu, Q; Yao, L; Yin, H; Yu, T | 1 |
| Chen, J; Qing, Y; Su, R | 1 |
| Bizarro, J; Deryusheva, S; Ernst, FGM; Gall, JG; Gupta, V; Lafontaine, DLJ; Meier, UT; Wacheul, L | 1 |
| Ernst, P; Yang, W | 1 |
| Sakata-Yanagimoto, M | 1 |
| Cartron, G; Cavalli, G; Herviou, L; Klein, B; Moreaux, J | 1 |
| Greenblatt, SM; Liu, F; Nimer, SD | 1 |
| Andricovich, J; Kai, Y; Tzatsos, A | 1 |
| Goodell, MA; Harmancey, R; Karlstaedt, A; Taegtmeyer, H; Vasquez, H; Vitrac, H; Wang, JH; Zhang, X | 1 |
| Allis, CD; Casadio, F; Dormann, HL; Li, H; Luo, JL; Patel, DJ; Song, J; Wang, GG; Wang, Z | 1 |
| Chen, CH; Yang, JP | 1 |
| Chim, CS; Chung, LP; Jin, DY; Lam, WW; Li, GK; Liang, R; Loong, F; So, CC; Wong, KY | 1 |
| Fog, CK; Galli, GG; Lund, AH | 1 |
| Bayar, E; Cortes, J; Faderl, S; Garcia-Manero, G; Giles, FJ; Issa, JP; Kantarjian, HM; Lyons, J; Mannari, R; Rosenfeld, CS; Thomas, D | 1 |
| Emi, M; Ezoe, S; Fujimoto, M; Kanakura, Y; Kanegane, H; Kawase, I; Kimura, A; Kishimoto, T; Matsumura, I; Miyawaki, T; Nagai, H; Naka, T; Saito, Y; Tachibana, I; Tanaka, T; Watanabe, D | 1 |
| Thomas, NR | 1 |
| Aguiar, RC; Alberta, J; Caron, S; Dahia, PL; Eng, C; Freedman, A; Kum, JB; Marsh, DJ; Ritz, J; Sill, H; Stiles, C | 1 |
11 review(s) available for isomethyleugenol and Hematologic Malignancies
| Article | Year |
|---|---|
[Research Progress of m6A Methylation Modification in Hematological Tumors--Review].
Topics: Adenosine; Epigenesis, Genetic; Hematologic Neoplasms; Humans; Methylation; Neoplasms; RNA, Messenger | 2022 |
Antitumor Effects of PRIMA-1 and PRIMA-1
Topics: Animals; Antineoplastic Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Hematologic Neoplasms; Humans; Methylation; Mutation; Tumor Suppressor Protein p53 | 2021 |
RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.
Topics: Animals; DNA Methylation; Epigenesis, Genetic; Hematologic Neoplasms; Histone Code; Histones; Humans; Methylation; RNA | 2021 |
RNA modifications in hematopoietic malignancies: a new research frontier.
Topics: Adenosine; Hematologic Neoplasms; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Methylation; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2021 |
Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis.
Topics: Animals; Enhancer Elements, Genetic; Gene Expression Regulation; Hematologic Neoplasms; Hematopoiesis; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Multigene Family; Organ Specificity; Promoter Regions, Genetic; Protein Binding | 2017 |
[TET2 dysregulation in hematologic malignancies].
Topics: Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Methylation; Molecular Targeted Therapy; Multigene Family; Mutation; Neoplasm Proteins; Proto-Oncogene Proteins | 2014 |
EZH2 in normal hematopoiesis and hematological malignancies.
Topics: Adenosine; B-Lymphocytes; Cell Differentiation; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Ethylenediamines; Gene Expression Regulation; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cells; Histones; Humans; Indoles; Methylation; Polycomb Repressive Complex 2; Precision Medicine; Pyrazoles; Pyridones | 2016 |
Arginine methyltransferases in normal and malignant hematopoiesis.
Topics: Animals; Blood Cells; Cell Differentiation; Cell Self Renewal; DNA Repair; Gene Expression; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cells; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Protein Isoforms; Protein-Arginine N-Methyltransferases; Signal Transduction | 2016 |
Lysine-specific histone demethylases in normal and malignant hematopoiesis.
Topics: Animals; Cell Transformation, Neoplastic; Gene Expression Regulation; Hematologic Neoplasms; Hematopoiesis; Histone Demethylases; Histones; Humans; Methylation; Signal Transduction | 2016 |
[Advances of research on demethylation therapy for hematologic malignancies].
Topics: DNA Methylation; Hematologic Neoplasms; Humans; Methylation | 2009 |
PRDM proteins: important players in differentiation and disease.
Topics: Adipose Tissue, Brown; Animals; Blood Vessels; Cell Differentiation; Gene Expression Regulation; Hematologic Neoplasms; Hematopoiesis; Histones; Humans; Isoenzymes; Methylation; Mice; Mice, Transgenic; Neoplasms; Organ Specificity; Protein Methyltransferases; Signal Transduction; Transcription, Genetic; Tumor Suppressor Proteins | 2012 |
1 trial(s) available for isomethyleugenol and Hematologic Malignancies
| Article | Year |
|---|---|
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cell Cycle Proteins; Cell Differentiation; Child; Child, Preschool; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Female; Gene Silencing; Hematologic Neoplasms; Humans; Karyotyping; Leukemia; Male; Methylation; Middle Aged; Myeloproliferative Disorders; Time Factors; Treatment Outcome; Tumor Suppressor Proteins | 2004 |
8 other study(ies) available for isomethyleugenol and Hematologic Malignancies
| Article | Year |
|---|---|
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.
Topics: Animals; Cell Line, Tumor; Deubiquitinating Enzymes; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Histones; Humans; Methylation; Polycomb Repressive Complex 2 | 2022 |
Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity.
Topics: Casein Kinase II; Cholangiocarcinoma; COVID-19 Drug Treatment; Hematologic Neoplasms; Humans; Interstitial Cells of Cajal; Methylation; Nuclear Proteins; Phosphoproteins; Phosphorylation; Ribonucleoproteins; RNA Splicing; RNA, Small Nuclear; Spliceosomes | 2021 |
Oncometabolite d-2-hydroxyglutarate impairs α-ketoglutarate dehydrogenase and contractile function in rodent heart.
Topics: Acetylation; Animals; ATP Citrate (pro-S)-Lyase; Cardiomyopathies; Glutarates; Hematologic Neoplasms; Histones; Humans; Isocitrate Dehydrogenase; Ketoglutarate Dehydrogenase Complex; Methylation; Mice; Mutation; Myocardium | 2016 |
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
Topics: Amino Acid Motifs; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Chromatin; Epigenesis, Genetic; Gene Expression Regulation, Developmental; Genes, Homeobox; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Magnetic Resonance Spectroscopy; Methylation; Mice; Models, Molecular; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Protein Binding; Protein Conformation; Retinoblastoma-Binding Protein 2; Transcription, Genetic; Tumor Suppressor Proteins | 2009 |
Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 6; Epigenesis, Genetic; Female; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylation; MicroRNAs; Middle Aged; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2011 |
Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Topics: Acute Disease; Carrier Proteins; Cell Line; Cell Line, Tumor; Gene Silencing; Genes, Tumor Suppressor; Hematologic Neoplasms; Hematopoiesis; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Leukemia, Myeloid; Methylation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins | 2004 |
Histone post-translational modification: from discovery to the clinic.
Topics: Acetylation; Animals; Antineoplastic Agents; Aurora Kinases; Benzamides; Clinical Trials as Topic; Depsipeptides; Hematologic Neoplasms; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Protein Conformation; Protein Kinase Inhibitors; Protein Methyltransferases; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Quinazolines | 2006 |
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Topics: Blotting, Northern; DNA Mutational Analysis; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; K562 Cells; Methylation; Mutation; Neoplasm Proteins; Phosphoric Monoester Hydrolases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1999 |